DK140003B - Method for isolating hemagglutinin and neuraminidase components from an influenza virus. - Google Patents

Method for isolating hemagglutinin and neuraminidase components from an influenza virus.

Info

Publication number
DK140003B
DK140003B DK1475AA DK1475A DK140003B DK 140003 B DK140003 B DK 140003B DK 1475A A DK1475A A DK 1475AA DK 1475 A DK1475 A DK 1475A DK 140003 B DK140003 B DK 140003B
Authority
DK
Denmark
Prior art keywords
hemagglutinin
isolating
influenza virus
neuraminidase
components
Prior art date
Application number
DK1475AA
Other languages
Danish (da)
Other versions
DK140003C (en
DK1475A (en
Inventor
Helmut Bachmayer
Gerhard Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK1475A publication Critical patent/DK1475A/da
Publication of DK140003B publication Critical patent/DK140003B/en
Application granted granted Critical
Publication of DK140003C publication Critical patent/DK140003C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DK1475AA 1974-01-14 1975-01-06 Method for isolating hemagglutinin and neuraminidase components from an influenza virus. DK140003B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (3)

Publication Number Publication Date
DK1475A DK1475A (en) 1975-09-01
DK140003B true DK140003B (en) 1979-06-05
DK140003C DK140003C (en) 1979-10-29

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
DK1475AA DK140003B (en) 1974-01-14 1975-01-06 Method for isolating hemagglutinin and neuraminidase components from an influenza virus.

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
NZ567817A (en) * 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Nanotherapeutics, Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Also Published As

Publication number Publication date
SE427238B (en) 1983-03-21
FR2257305A1 (en) 1975-08-08
YU41289B (en) 1987-02-28
HK56380A (en) 1980-10-16
JPS58407B2 (en) 1983-01-06
NL166622C (en) 1981-09-15
FR2257305B1 (en) 1982-03-19
ES433759A1 (en) 1977-02-16
NO143128B (en) 1980-09-15
BE824372A (en) 1975-07-14
AU7730575A (en) 1976-07-15
CS191254B2 (en) 1979-06-29
MY8100204A (en) 1981-12-31
YU5875A (en) 1984-04-30
DE2500785A1 (en) 1975-07-31
HU173920B (en) 1979-09-28
GB1498261A (en) 1978-01-18
DK140003C (en) 1979-10-29
PH14458A (en) 1981-07-29
FI750014A (en) 1975-07-15
DE2500785B2 (en) 1980-01-03
SU616997A3 (en) 1978-07-25
FI54053C (en) 1978-10-10
NL166622B (en) 1981-04-15
SE7500130L (en) 1975-07-15
DD116239A5 (en) 1975-11-12
JPS56127319A (en) 1981-10-06
PL93689B1 (en) 1977-06-30
NO750031L (en) 1975-08-11
IL46426A (en) 1978-01-31
DE2500785C3 (en) 1980-09-11
JPS6035326B2 (en) 1985-08-14
CH589453A5 (en) 1977-07-15
AT345449B (en) 1978-09-11
AU500250B2 (en) 1979-05-17
IL46426A0 (en) 1975-04-25
NO143128C (en) 1980-12-29
ZA75259B (en) 1976-08-25
IE40794B1 (en) 1979-08-15
IE40794L (en) 1975-07-14
DK1475A (en) 1975-09-01
FI54053B (en) 1978-06-30
CA1049406A (en) 1979-02-27
NL7500301A (en) 1975-07-16
ATA21475A (en) 1978-01-15
JPS50100224A (en) 1975-08-08

Similar Documents

Publication Publication Date Title
DK138800B (en) Analogous process for the preparation of 4-aminoquinazoline derivatives.
DK402075A (en) PROCEDURE FOR THE PREPARATION OF ORGANIC COMPOUNDS INCLUDING THE CYCLOPROPANE SYSTEM
DK139024B (en) Apparatus for cleaning containers.
DK117219B (en) Process for the preparation of a 4-aryl-3-hydroxybutyric acid or an ester or an amide thereof.
DK155943C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 7-D - (-) - ALFA-AMINO-ALFA- (P-ACETOXYPHENYL) ACETAMIDOCEPHALOSPORAN ACIDS
DK511975A (en) APPARATUS FOR PAPING LABELS
DK140003B (en) Method for isolating hemagglutinin and neuraminidase components from an influenza virus.
DK157246C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N-ACYLAMINO-ALFA-PHENYLACETAMIDOCEPHALOSPORINES OR PHARMACEUTICAL ACCEPTABLE SALTS.
DK162134C (en) PROCEDURE FOR THE EXTRACTION OF PROTEINS FROM POTATOES
DK140555B (en) Method for purification of urokinase.
DK147854C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N- (1-BENZYLPIPERID-4-YL) -BENZAMIDES
AT354820B (en) FLANGE CONNECTION, ESPECIALLY FOR COMPONENTS OF VACUUM APPARATUS
DK127370B (en) Method for removing a selected component from a gas stream.
IT1042239B (en) APPARATUS AND METHOD FOR THE SEPARATION OF A CRYOPRECIPITATED BY BLOOD PLASMA
NL7415614A (en) INFLUENZA ACCINES AND METHOD FOR PREPARING THEM
DK146718C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF BENZOBICYCLONONES
DK136313B (en) Analogous process for the preparation of N-substituted m-trifluoromethylbenzylamines.
DK110208C (en) Process for the preparation of influenza vaccines.
DK216575A (en) METHOD FOR THE PREPARATION OF METHYLAMINE DERIVATIVES
DK138694B (en) Process for the preparation of phenylphosphonothiodichloride.
DK137646B (en) Process for the preparation of 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide.
DK139207B (en) Apparatus for testing wheel tracking.
DK199175A (en) ARRANGEMENT FOR FIXING PANELS
DK138698B (en) Process for the preparation of 13-ethynyl steroids.
DK136820B (en) Analogous process for the preparation of 2-ketoglutarate by vincamine.

Legal Events

Date Code Title Description
PBP Patent lapsed